SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Problems of using modelling in the economic evaluation of health care
12 references·11 citing·49 second hop
Problems of using modelling in the economic evaluation of health care (1996)Problems of using modelling in the econom…Reporting guidelines for economic studies (1995)Reporting guidelines for econ…Misleading meta-analysis (1995)Misleading meta-analysisMeta-analysis: Statistical alchemy for the 21st century (1995)Meta-analysis: Statistical al…“The challenge of meta-analysis”: Discussion. Indications and contra-indications for meta-analysis (1995)“The challenge of meta-analys…What Price Depression? (1994)What Price Depression?Uncertainty in the economic evaluation of health care technologies: The role of sensitivity analysis (1994)Uncertainty in the economic e…The scandal of poor medical research (1994)The scandal of poor medical r…The miracle of DICE therapy for acute stroke: fact or fictional product of subgroup analysis? (1994)The miracle of DICE therapy f…The Journal's Policy on Cost-Effectiveness Analyses (1994)The Journal's Policy on Cost-…Importance of trends in the interpretation of an overall odds ratio in the meta‐analysis of clinical trials (1994)Importance of trends in the i…Cost-Effectiveness and Cost-Benefit Analyses in the Medical Literature (1992)Cost-Effectiveness and Cost-B…Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis (1989)Methodology and overt and hid…A new innovative method to evaluate public news broadcasting: Preserving democracy, culture, and identity during the first AI revolution (2025)A new innovative method to ev…Development and Validation of a Markov Microsimulation Model for the Economic Evaluation of Treatments in Osteoporosis (2009)Development and Validation of…Complexity and reflexivity: Two important issues for economic evaluation in health care (2007)Complexity and reflexivity: T…ECONOMIC EVALUATION IN ORTHOPAEDICS (2003)ECONOMIC EVALUATION IN ORTHOP…The cost-effectiveness of magnetic resonance angiography for carotid artery stenosis and peripheral vascular disease: a systematic review (2002)The cost-effectiveness of mag…AMCP Guidance for Submission of Clinical and Economic Evaluation Data to Support Formulary Listing in U.S. Health Plans and Pharmacy Benefits Management Organizations (2001)AMCP Guidance for Submission …Testing the Validity of Cost-Effectiveness Models (2000)Testing the Validity of Cost-…Rational decision-making in mental health: the role of systematic reviews (1999)Rational decision-making in m…Costs of Diabetes (1999)Costs of DiabetesAssessing the costs of healthcare technologies in clinical trials. (1999)Assessing the costs of health…Health and Economic Outcomes Modeling Practices: A Suggested Framework (1998)Health and Economic Outcomes …Regression Towards Mediocrity in Hereditary Stature. (1886)Primary, Secondary, and Meta-Analysis of Research (1976)A method for assessing the quality of a randomized control trial (1981)A Proposal for Structured Reporting of Randomized Controlled Trials (1994)The Importance of Quality of Primary Studies in Producing Unbiased Systematic Reviews (1996)Recommendations by Cochrane Review Groups for assessment of the risk of bias in studies (2008)Publication bias: the case for an international registry of clinical trials. (1986)Why do we need systematic overviews of randomized trials? (Transcript of an oral presentation, modified by the editors) (1987)Publication bias in clinical research (1991)From Science to Practice (1995)Doing New Research? Don't Forget the Old (2004)Can electronic monitoring reduce crime for moderate to high-risk offenders? (2005)Methods for the economic evaluation of health care programmes (1987)Psychiatric disorders in America: the epidemiologic catchment area study (1991)Depression: cost-of-illness studies in the international literature, a review (2000)The economic burden of coronary heart disease in the UK (2002)Clinical decision analysis (2005)Measurement of health state utilities for economic appraisal (1986)How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)Handling uncertainty when performing economic evaluation of healthcare interventions. (1999)Generalisability in economic evaluation studies in healthcare: a review and case studies (2004)Interpreting the Results of Cost-Effectiveness Studies (2008)A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction (1992)Formulating Questions and Locating Primary Studies for Inclusion in Systematic Reviews (1997)Multivariate meta‐analysis: Potential and promise (2011)Consequences of bullying victimization in childhood and adolescence: A systematic review and meta-analysis (2017)Meta-Analysis in Clinical Research (1987)An Assessment of Clinically Useful Measures of the Consequences of Treatment (1988)Methods for Trend Estimation from Summarized Dose-Response Data, with Applications to Meta-Analysis (1992)Of apples and oranges, file drawers and garbage: Why validity issues in meta-analysis will not go away (1997)Sex differences on the progressive matrices: A meta-analysis (2004)Cultural meaning of perceived control: A meta-analysis of locus of control and psychological symptoms across 18 cultural regions. (2012)Foundations of Cost-Effectiveness Analysis for Health and Medical Practices (1977)A Clinician's Guide to Cost-Effectiveness Analysis (1990)Examining the Value and Quality of Health Economic Analyses: Implications of Utilizing the QHES (2003)Technology Assessment (2005)New Information for Authors — And Readers (1990)Problems With the Interpretation of Pharmacoeconomic Analyses (2000)Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis* (2003)Medicare and Cost-Effectiveness Analysis (2005)Health Measurement Scales: A Practical Guide to Their Development and Use (1989)Cost-Effectiveness in Health and Medicine (1996)Methods for the Economic Evaluation of Health Care Programmes (2005)Direct costs associated with depression in old age in Germany (2007)An Improved Set of Standards for Finding Cost for Cost-Effectiveness Analysis (2009)Step-by-step guideline for disease-specific costing studies in low- and middle-income countries: a mixed methodology (2014)Educational Research, Policymaking and Practice (2002)The Impact of Study Size on Meta-analyses: Examination of Underpowered Studies in Cochrane Reviews (2013)Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances (2021)
this work references cited by second hop

References

  • 1994The scandal of poor medical research897 cited
  • 1994Uncertainty in the economic evaluation of health care technologies: The role of sensitivity analysis521 cited
  • 1995Misleading meta-analysis508 cited
  • 1992Cost-Effectiveness and Cost-Benefit Analyses in the Medical Literature410 cited
  • 1995Meta-analysis: Statistical alchemy for the 21st century338 cited
  • 1989Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis338 cited
  • 1994The Journal's Policy on Cost-Effectiveness Analyses233 cited
  • 1994What Price Depression?222 cited
  • 1994The miracle of DICE therapy for acute stroke: fact or fictional product of subgroup analysis?148 cited
  • 1994Importance of trends in the interpretation of an overall odds ratio in the meta‐analysis of clinical trials89 cited
  • 1995Reporting guidelines for economic studies72 cited
  • 1995“The challenge of meta-analysis”: Discussion. Indications and contra-indications for meta-analysis45 cited

Cited by

  • 1999Assessing the costs of healthcare technologies in clinical trials.150 cited
  • 2002The cost-effectiveness of magnetic resonance angiography for carotid artery stenosis and peripheral vascular disease: a systematic review

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

111 cited
  • 2000Testing the Validity of Cost-Effectiveness Models95 cited
  • 2003ECONOMIC EVALUATION IN ORTHOPAEDICS83 cited
  • 2009Development and Validation of a Markov Microsimulation Model for the Economic Evaluation of Treatments in Osteoporosis81 cited
  • 2007Complexity and reflexivity: Two important issues for economic evaluation in health care72 cited
  • 2001AMCP Guidance for Submission of Clinical and Economic Evaluation Data to Support Formulary Listing in U.S. Health Plans and Pharmacy Benefits Management Organizations71 cited
  • 1998Health and Economic Outcomes Modeling Practices: A Suggested Framework70 cited
  • 1999Costs of Diabetes65 cited
  • 1999Rational decision-making in mental health: the role of systematic reviews19 cited
  • 2025A new innovative method to evaluate public news broadcasting: Preserving democracy, culture, and identity during the first AI revolution10 cited